Consistent with our results, a recent study reported that MSC overexpressed HNF4α could enhance the therapeutic effects on CCl4-induced mouse liver cirrhosis model by reducing inflammation and liver injury [43]. The gene discussed is HNF4A; the disease is cirrhosis of liver.